2015 Aug;81(12-13):1141-1145. Epub 2015 May 8.Nazir M1, Harms H1, Loef I1, Kehraus S1, El Maddah F1, Arslan I2, Rempel V3, Müller CE3, König GM1.
Abstract
The marine sponge-derived fungus Auxarthron reticulatum produces the cannabinoid receptor antagonist amauromine (1). Recultivation of the fungus to obtain further amounts for more detailed pharmacological evaluation of 1 additionally yielded the novel triterpene glycoside auxarthonoside (2), bearing, in nature, a rather rare sugar moiety, i.e., N-acetyl-6-methoxy-glucosamine. Amauromine (1), which inhibited cannabinoid CB1 receptors (Ki 0.178 µM) also showed antagonistic activity at the cannabinoid-like orphan receptor GPR18 (IC50 3.74 µM). The diketopiperazine 1 may thus serve as a lead structure for the development of more potent and selective GPR18 antagonists, which are required to study the orphan receptor’s potential as a new drug target. Despite the execution of many biological assays, to date, no bioactivity could be found for auxarthonoside (2).
Georg Thieme Verlag KG Stuttgart · New York.
Georg Thieme Verlag KG Stuttgart · New York.
- PMID:
26287693
[PubMed – as supplied by publisher]